Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Research Award: Canada Graduate Scholarships

University of Toronto

$105,000.00

Modelling Chr13q Deletion in Human Hematopoietic Stem Cells and its Role in Clonal Hematopoiesis and the Pre-Leukemic State

FY 2022-23

Summary
Supervisor: Dr. John E. Dick; Institution: University of Toronto. Every day, 18 Canadians are diagnosed with leukemia and 10 die from this devastating blood cancer. Although leukemia usually happens when a normal blood-producing stem cell accumulates changes in their DNA that occur over decades, leukemia patients only seek medical attention when they experience symptoms and life-threatening complications. Thus, there is great need for earlier detection and intervention. Recently, we identified pre-leukemic blood-producing stem cells up to a decade before a patient's diagnosis, setting the stage for a new approach to predict leukemic risk in asymptomatic individuals. However, there are no available treatments to stop leukemia progression in high-risk individuals despite the breakthrough in early detection. To address this gap, I will create a humanized pre-leukemia model by generating changes specific to the pre-leukemic state in healthy human blood-producing stem cells using gene editing technology, and placing them into immune-compromised mice to observe its effects in cell maintenance and blood cell production. A distinct bias in the types and numbers of cells produced will reveal potential clinical diagnostic indicators of pre-leukemia. I will also apply state-of-the-art single-cell sequencing technology and computational methods to identify unique networks that govern the pre-leukemic state in these stem cells. Future studies can therapeutically exploit these networks by targeting candidates that specifically govern the pre-leukemic blood-producing stem cells, while leaving the normal blood-producing stem cells unharmed. Overall, the results from this study will uncover the nature of pre-leukemic blood-producing stem cells and illustrate a trajectory for pre-leukemia development. My findings offer a new strategy for bringing early intervention approaches into the healthcare system for leukemia prevention.
Program
Doctoral Research Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
475724
Name
Wong Gordon
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Modelling Chr13q Deletion in Human Hematopoietic Stem Cells and its Role in Clonal Hematopoiesis and the Pre-Leukemic State
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Age-Related Clonal Hematopoiesis; Crispr-Cas9 Genomic Engineering; Pre-Leukemic Stem Cell; Single-Cell In Vitro Differentiation Assay; Single-Cell Multi-Ome Assay (Atac+Rna-Seq); Xenotransplantation
Abstract
Supervisor: Dr. John E. Dick; Institution: University of Toronto. Every day, 18 Canadians are diagnosed with leukemia and 10 die from this devastating blood cancer. Although leukemia usually happens when a normal blood-producing stem cell accumulates changes in their DNA that occur over decades, leukemia patients only seek medical attention when they experience symptoms and life-threatening complications. Thus, there is great need for earlier detection and intervention. Recently, we identified pre-leukemic blood-producing stem cells up to a decade before a patient's diagnosis, setting the stage for a new approach to predict leukemic risk in asymptomatic individuals. However, there are no available treatments to stop leukemia progression in high-risk individuals despite the breakthrough in early detection. To address this gap, I will create a humanized pre-leukemia model by generating changes specific to the pre-leukemic state in healthy human blood-producing stem cells using gene editing technology, and placing them into immune-compromised mice to observe its effects in cell maintenance and blood cell production. A distinct bias in the types and numbers of cells produced will reveal potential clinical diagnostic indicators of pre-leukemia. I will also apply state-of-the-art single-cell sequencing technology and computational methods to identify unique networks that govern the pre-leukemic state in these stem cells. Future studies can therapeutically exploit these networks by targeting candidates that specifically govern the pre-leukemic blood-producing stem cells, while leaving the normal blood-producing stem cells unharmed. Overall, the results from this study will uncover the nature of pre-leukemic blood-producing stem cells and illustrate a trajectory for pre-leukemia development. My findings offer a new strategy for bringing early intervention approaches into the healthcare system for leukemia prevention.
Competitiondate
202211
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Wong, Gordon
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~